Free Access
Issue
Med Sci (Paris)
Volume 27, Number 11, Novembre 2011
Page(s) 1028 - 1034
Section Prix Nobel 2011
DOI https://doi.org/10.1051/medsci/20112711022
Published online 30 November 2011
  1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice: morphology, quantitation, tissue distribution. J Exp Med 1973 ; 137 : 1142–1162. [CrossRef] [PubMed] [Google Scholar]
  2. Steinman RM, Witmer MD. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci USA 1978 ; 75 : 5132–5136. [CrossRef] [Google Scholar]
  3. Nussenzweig MC, Steinman RM, Unkeless JC, et al. Studies of the cell surface of mouse dendritic cells and other leukocytes. J Exp Med 1981 ; 154 : 168–187. [CrossRef] [PubMed] [Google Scholar]
  4. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007 ; 37 : S53–S60. [CrossRef] [PubMed] [Google Scholar]
  5. Nussenzweig MC, Steinman RM, Witmer MD, Gutchinov B. A monoclonal antibody specific for mouse dendritic cells. Proc Natl Acad Sci USA 1982 ; 79 : 161–165. [CrossRef] [Google Scholar]
  6. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982 ; 155 : 31–41. [CrossRef] [PubMed] [Google Scholar]
  7. Faustman DL, Steinman RM, Gebel HM, et al. Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci USA 1984 ; 81 : 3864–3868. [CrossRef] [Google Scholar]
  8. Steinman RM, Gutchinov B, Witmer MD, Nussenzweig MC. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J Exp Med 1983 ; 157 : 613–627. [CrossRef] [PubMed] [Google Scholar]
  9. Nussenzweig MC, Steinman RM, Gutchinov B, Cohn ZA. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J Exp Med 1980 ; 152 : 1070–1084. [CrossRef] [PubMed] [Google Scholar]
  10. Inaba K, Steinman RM. Protein-specific helper T lymphocyte formation initiated by dendritic cells. Science 1985 ; 229 : 475–479. [CrossRef] [PubMed] [Google Scholar]
  11. Crowley M, Inaba K, Steinman RM. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 1990 ; 172 : 383–386. [CrossRef] [PubMed] [Google Scholar]
  12. Inaba K, Metlay JP, Crowley MT, Steinman RM. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHCrestricted T cells in situ. J Exp Med 1990 ; 172 : 631–640. [CrossRef] [PubMed] [Google Scholar]
  13. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007 ; 449 : 419–426. [CrossRef] [PubMed] [Google Scholar]
  14. Janeway CAJr.. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989 ; 54 : 1–13. [CrossRef] [Google Scholar]
  15. Matzinger P. Tolerance, danger, and the extended family. Annual Rev Immunol 1994 ; 12 : 991–1045. [CrossRef] [PubMed] [Google Scholar]
  16. Inaba K, Young JW, Steinman RM. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J Exp Med 1987 ; 166 : 182–194. [CrossRef] [PubMed] [Google Scholar]
  17. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005 ; 23 : 975–1028. [CrossRef] [PubMed] [Google Scholar]
  18. Bar-On L, Jung S. Defining dendritic cells by conditional and constitutive cell ablation. Immunol Rev 2010 ; 234 : 76–89. [CrossRef] [PubMed] [Google Scholar]
  19. Jung S, Unutmaz D, Wong P, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002 ; 17 : 211–220. [CrossRef] [PubMed] [Google Scholar]
  20. Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999 ; 5 : 405–411. [CrossRef] [PubMed] [Google Scholar]
  21. Ikarashi Y, Mikami R, Bendelac A, et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J Exp Med 2001 ; 194 : 1179–1186. [CrossRef] [PubMed] [Google Scholar]
  22. Ferlazzo G, Tsang ML, Moretta L, et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the nkp30 receptor by activated NK cells. J Exp Med 2002 ; 195 : 343–351. [CrossRef] [PubMed] [Google Scholar]
  23. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002 ; 2 : 151–161. [CrossRef] [PubMed] [Google Scholar]
  24. Hoeffel G, Ripoche AC, Matheoud D, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007 ; 27 : 481–492. [CrossRef] [PubMed] [Google Scholar]
  25. Ginhoux F, Liu K, Helft J, et al. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 2009 ; 206 : 3115–3130. [CrossRef] [PubMed] [Google Scholar]
  26. Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic cells. Science 2010 ; 327 : 656–661. [CrossRef] [PubMed] [Google Scholar]
  27. Varol C, Landsman L, Fogg DK, et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 2007 ; 204 : 171–180. [CrossRef] [PubMed] [Google Scholar]
  28. Jiang W, Swiggard WJ, Heufler C, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995 ; 375 : 151–155. [CrossRef] [PubMed] [Google Scholar]
  29. Bonifaz L, Bonnyay D, Mahnke K, et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002 ; 196 : 1627–1638. [CrossRef] [PubMed] [Google Scholar]
  30. Liu K, Iyoda T, Saternus M, et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002 ; 196 : 1091–1097. [CrossRef] [PubMed] [Google Scholar]
  31. Watanabe N, Wang YH, Lee HK, et al. Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005 ; 436 : 1181–1185. [CrossRef] [PubMed] [Google Scholar]
  32. Luo X, Tarbell KV, Yang H, et al. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25–T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2007 ; 104 : 2821–2826. [CrossRef] [Google Scholar]
  33. Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25+ CD4+ regulatory Tcells by antigen processing dendritic cells. J Exp Med 2003 ; 198 : 235–247. [CrossRef] [PubMed] [Google Scholar]
  34. Ghiringhelli F, Puig PE, Roux S, et al. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med 2005 ; 202 : 919–929. [CrossRef] [PubMed] [Google Scholar]
  35. Kool M, Lambrecht BN. Dendritic cells in asthma and COPD: opportunities for drug development. Curr Opin Immunol 2007 ; 19 : 701–710. [CrossRef] [PubMed] [Google Scholar]
  36. Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011 ; 365 : 127–138. [CrossRef] [PubMed] [Google Scholar]
  37. Hildner K, Edelson BT, Purtha WE, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008 ; 322 : 1097–1100. [CrossRef] [PubMed] [Google Scholar]
  38. Stary G, Bangert C, Tauber M, et al. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 2007 ; 204 : 1441–1451. [CrossRef] [PubMed] [Google Scholar]
  39. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998 ; 392 : 86–89. [CrossRef] [PubMed] [Google Scholar]
  40. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007 ; 13 : 1050–1059. [CrossRef] [PubMed] [Google Scholar]
  41. Dhodapkar M, Steinman RM, Sapp M, et al. Rapid generation of broad T-cell immunity in humans after single injection of mature dendritic cells. J Clin Invest 1999 ; 104 : 173–180. [CrossRef] [PubMed] [Google Scholar]
  42. Dhodapkar MV, Bhardwaj N. Active immunization of humans with dendritic cells. J Clin Immunol 2000 ; 20 : 167–174. [CrossRef] [PubMed] [Google Scholar]
  43. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996 ; 183 : 87–97. [CrossRef] [PubMed] [Google Scholar]
  44. Cheever MA, Higano CS. Provenge (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin Cancer Res 2011 ; 17 : 3520–3526. [CrossRef] [PubMed] [Google Scholar]
  45. Bonifaz L, Bonnyay D, Mahnke K, et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002 ; 196 : 1627–1638. [CrossRef] [PubMed] [Google Scholar]
  46. Bozzacco L, Trumpfheller C, Siegal FP, et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA 2007 ; 104 : 1289–1294. [CrossRef] [Google Scholar]
  47. Nchinda G, Kuroiwa J, Oks M, et al. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest 2008 ; 118 : 1427–1432. [CrossRef] [PubMed] [Google Scholar]
  48. Bashyam H. Ralph Steinman: dendritic cells bring home the Lasker. J Exp Med 2007 ; 204 : 2245–2248. [CrossRef] [PubMed] [Google Scholar]
  49. Lotteau V. Prix Nobel de Médecine 1996 : Peter C. Doherty et Rolf M. Zinkernagel. La restriction de la réponse immunitaire par le complexe majeur d’histocompatibilité. Med Sci (Paris) 1996 ; 12 : 1316–1318. [CrossRef] [Google Scholar]
  50. Mukherjee S. The Emperor of all maladies: a biography of cancer. New York : Scribner, 2010 : 592 p. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.